Early Identification of High-Risk Individuals for Mortality after Lung Transplantation: A Retrospective Cohort Study with Topological Transformers

Abstract

Background and Objective Lung transplantation remains the only definitive treatment for patients with end-stage respiratory failure; however, it is burdened by a substantial risk of post-operative mortality. Current risk stratification methods, such as the Lung Transplant Risk Index, offer limited predictive performance and interpretability. This study introduces a novel predictive model based on topological transformers to assess mortality risk following lung transplantation. The objective is to improve predictive accuracy by capturing complex temporal patterns in clinical data while ensuring model interpretability to inform clinical decisions. Methods A retrospective cohort study was conducted using clinical data from lung transplant recipients. The model integrates both static and time-dependent clinical variables through a transformer-based architecture that incorporates topological features derived from patients’ temporal trajectories. Model performance was compared to established methods using a held-out test set. The evaluation metrics included accuracy, sensitivity, specificity, and the area under the receiver operating characteristic curve. Model interpretability was assessed using Shapley Additive explanations to identify and rank the most influential predictors of mortality. Results The proposed model demonstrated superior predictive performance compared to the Lung Transplant Risk Index and other benchmark models. On the test dataset, it achieved an accuracy of 87.4%, sensitivity of 84.1%, and specificity of 89.6%. The model consistently outperformed existing approaches across different subgroups, including age, underlying disease, and transplant type. Shapley-based interpretability analysis revealed that dynamic variables such as early post-operative oxygenation trends, immunosuppressive load, and inflammatory markers were among the most critical contributors to mortality risk. Conclusions The integration of topological features within a transformer-based framework significantly enhances the prediction of post-transplant mortality risk. By offering both improved predictive power and model transparency, this approach supports more precise and personalised risk stratification in lung transplantation. These findings highlight the potential of topological transformers as a valuable tool in the broader context of precision medicine and clinical decision support.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The author(s) received no specific funding for this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Research ethics approval: This work received approval from the Ethics Committee at the Bitchat Hospital, Université de Paris Cité. Ethics Statement: This study was approved by the Partners Human Research Committee, which waived the requirement for informed consent for the collection and analysis of samples.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Comments (0)

No login
gif